Breaking News Instant updates and real-time market news.

STRM

Streamline Health

$0.90

(0.00%)

, WFC

Wells Fargo

$52.54

-0.77 (-1.44%)

16:17
11/20/18
11/20
16:17
11/20/18
16:17

Streamline Health extends banking agreement with Wells Fargo into 2020

Streamline Health Solutions (STRM) announced it extended its banking agreement with Wells Fargo (WFC) into its fiscal year 2020. The original agreement with Wells Fargo was to expire in November of 2019.

STRM

Streamline Health

$0.90

(0.00%)

WFC

Wells Fargo

$52.54

-0.77 (-1.44%)

  • 12

    Apr

  • 13

    Jul

  • 12

    Oct

STRM Streamline Health
$0.90

(0.00%)

WFC Wells Fargo
$52.54

-0.77 (-1.44%)

11/02/18
SBSH
11/02/18
UPGRADE
SBSH
Buy
Wells Fargo upgraded to Buy from Neutral at Citi
Citi analyst Keith Horowitz upgraded Wells Fargo to Buy.
10/15/18
BMOC
10/15/18
NO CHANGE
Target $65
BMOC
Market Perform
Wells Fargo price target raised to $65 from $61 at BMO Capital
BMO Capital analyst James Fotheringham raised his price target on Wells Fargo to $65 in spite of its Q3 revenue miss as he raises his FY19 EPS view by 1c to $5.23 to reflect lower expected credit costs. The analyst also notes that financials are "cheap again" in spite of the rising interest rates which are positive for net interest margins, better employment which is positive for credit, and regulatory relief which is positive for their capital position. Fotheringham also keeps his Market Perform rating on Wells Fargo, saying that while the bank's valuation is getting "cheap" for the first time since he launched coverage, better opportunities exist in other large-cap financials.
10/15/18
10/15/18
UPGRADE
Target $62

Outperform
Wells Fargo upgraded to Outperform, visibility improving, says Macquarie
As previously reported, Macquarie upgraded Wells Fargo to Outperform from neutral with a $62 price target. Analyst David Konrad said Wells Fargo shares are trading at a 10% discount to peers and believes investors will warm up to the company's self-help story of meaningful expense savings over the next two years combined with better than peer buybacks. Konrad notes revenue growth will be challenging, but is encouraged by signs from consumers in the form of improved checking account and card growth, and moderating FA turnover.
10/15/18
MACQ
10/15/18
UPGRADE
MACQ
Outperform
Wells Fargo upgraded to Outperform from Neutral at Macquarie

TODAY'S FREE FLY STORIES

LULU

Lululemon

$119.13

-1.08 (-0.90%)

05:42
12/17/18
12/17
05:42
12/17/18
05:42
Upgrade
Lululemon rating change  »

Lululemon upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jan

  • 15

    Jan

AXON

Axovant Sciences

$1.01

-0.12 (-10.62%)

05:36
12/17/18
12/17
05:36
12/17/18
05:36
Upgrade
Axovant Sciences rating change  »

Axovant Sciences upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPI

SPI Energy

$1.19

-0.02 (-1.65%)

05:36
12/17/18
12/17
05:36
12/17/18
05:36
Hot Stocks
SPI Energy receives delinquency notice from Nasdaq »

SPI Energy announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDRBF

Bombardier

$0.00

(0.00%)

05:35
12/17/18
12/17
05:35
12/17/18
05:35
Hot Stocks
Bombardier to supply a further 20 FLEXITY trams to Karlsruhe »

Global mobility solution…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

THC

Tenet

$21.24

-2.25 (-9.58%)

05:32
12/17/18
12/17
05:32
12/17/18
05:32
Downgrade
Tenet rating change  »

Tenet downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EMR

Emerson

$60.45

-0.29 (-0.48%)

05:31
12/17/18
12/17
05:31
12/17/18
05:31
Downgrade
Emerson rating change  »

Emerson downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MFA

MFA Financial

$6.98

-0.01 (-0.14%)

05:27
12/17/18
12/17
05:27
12/17/18
05:27
Upgrade
MFA Financial rating change  »

MFA Financial upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INCY

Incyte

$66.24

-1.04 (-1.55%)

05:27
12/17/18
12/17
05:27
12/17/18
05:27
Hot Stocks
Incyte, Innovent announce strategic collaboration, licensing agreement »

Incyte and Innovent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

CSL

Carlisle

$96.53

-1.69 (-1.72%)

05:26
12/17/18
12/17
05:26
12/17/18
05:26
Upgrade
Carlisle rating change  »

Carlisle upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHHBY

Roche

$0.00

(0.00%)

05:25
12/17/18
12/17
05:25
12/17/18
05:25
Hot Stocks
Roche SMA treatment risdiplam granted PRIME designation by EMA »

Roche announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Dec

  • 18

    Mar

SMG

Scotts Miracle-Gro

05:25
12/17/18
12/17
05:25
12/17/18
05:25
Upgrade
Scotts Miracle-Gro rating change  »

Scotts Miracle-Gro…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MFA

MFA Financial

$6.98

-0.01 (-0.14%)

05:24
12/17/18
12/17
05:24
12/17/18
05:24
Upgrade
MFA Financial rating change  »

MFA Financial upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGI

Triumph Group

$13.23

0.13 (0.99%)

05:18
12/17/18
12/17
05:18
12/17/18
05:18
Upgrade
Triumph Group rating change  »

Triumph Group upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LYB

LyondellBasell

$82.34

-1.35 (-1.61%)

05:16
12/17/18
12/17
05:16
12/17/18
05:16
Upgrade
LyondellBasell rating change  »

LyondellBasell upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EC

Ecopetrol

$18.36

-0.33 (-1.77%)

, YPF

YPF

$14.38

0.03 (0.21%)

05:11
12/17/18
12/17
05:11
12/17/18
05:11
Recommendations
Ecopetrol, YPF, Petrobras analyst commentary  »

Ecopetrol price target…

EC

Ecopetrol

$18.36

-0.33 (-1.77%)

YPF

YPF

$14.38

0.03 (0.21%)

PBR

Petrobras

$13.40

-0.235 (-1.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALK

Alaska Air

$62.29

0.96 (1.57%)

05:04
12/17/18
12/17
05:04
12/17/18
05:04
Recommendations
Alaska Air analyst commentary  »

Alaska Air called a top…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVYA

Avaya

$17.58

-0.14 (-0.79%)

04:59
12/17/18
12/17
04:59
12/17/18
04:59
Initiation
Avaya initiated  »

Avaya initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARGX

Argenx

$102.30

-0.94 (-0.91%)

04:57
12/17/18
12/17
04:57
12/17/18
04:57
Initiation
Argenx initiated  »

Argenx initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORTX

Orchard Therapeutics

$15.00

-0.01 (-0.07%)

04:56
12/17/18
12/17
04:56
12/17/18
04:56
Upgrade
Orchard Therapeutics rating change  »

Orchard Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHW

Sherwin-Williams

$385.73

-0.075 (-0.02%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Upgrade
Sherwin-Williams rating change  »

Sherwin-Williams upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACHN

Achillion

$3.12

0.035 (1.14%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
Achillion to hold a conference call »

Dr. Stephen Zelenkofske,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

MDP

Meredith

$53.26

-0.54 (-1.00%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
Meredith management to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

EQH

AXA Equitable

$16.87

-0.67 (-3.82%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
AXA Equitable to hold a conference call »

Investor Conference call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

AEYE

AudioEye

$6.99

-0.09 (-1.27%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
AudioEye management to meet with B. Riley FBR »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

TLRA

Telaria

$2.81

-0.02 (-0.71%)

04:55
12/17/18
12/17
04:55
12/17/18
04:55
Conference/Events
Telaria management to meet with Lake Street »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 18

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.